Verifying…
Home / Registered in Nigeria / Apetafast Syrup

Apetafast Syrup

NAFDAC Reg. No. C4-1198 · Drug

Registered with NAFDAC. Registration activeAs of 31 October 2026 · synced automatically from official sources.
Product
Apetafast Syrup
NAFDAC number
C4-1198
Active ingredient
Cyproheptadine; Vitamins
Strength
see Composition
Form
Syrup
Pack size
200 mL
Manufacturer
Not listed
Applicant (holder)
JSP Pharma Company Nigeria Limited
Approved
10 Nov 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
9 Nov 2025
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Cyproheptadine: uses, dosage and brands worldwide

What we found

  • Apetafast Syrup is on the NAFDAC register with an active registration (C4-1198). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Apetafast Syrup

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Perennial and seasonal allergic rhinitis, Vasomotor rhinitis, Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Cold urticaria. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

How to take it and how often
  • DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT
  • Children: The total daily dosage for children may be calculated on the basis of body weight or body area using approximately 0.25 mg/kg/day (0.11 mg/lb/day) or 8 mg per square meter of body surface (8 mg/m 2 )
  • In small children for whom the calculation of the dosage based upon body size is important, it may be necessary to use cyproheptadine syrup to permit accurate dosage
  • Age 2 to 6 years: The usual dose is 2 mg (1/2 tablet) two or three times a day, adjusted as necessary to the size and response of the patient
  • The dose is not to exceed 12 mg a day
  • Age 7 to 14 years: The usual dose is 4 mg (1 tablet) two or three times a day, adjusted as necessary to the size and response of the patient
  • The dose is not to exceed 16 mg a day
  • Adults: The total daily dose for adults should not exceed 0.5 mg/kg/day (0.23 mg/lb/day)
  • The therapeutic range is 4 to 20 mg a day, with the majority of patients requiring 12 to 16 mg, a day
  • An occasional patient may require as much as 32 mg a day for adequate relief
  • It is suggested that dosage be initiated with 4 mg (1 tablet) three times a day and adjusted according to the size and response of the patient
Talk to a doctor first if
  • Newborn or Premature
  • Infants: This drug should not be used in newborn or premature
  • Infants
  • Nursing Mothers: Because of the higher risk of antihistamines for infants generally, and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers
  • Other Conditions: Hypersensitivity to cyproheptadine and other drugs of similar chemical structure
  • Monoamine oxidase inhibitor therapy (see DRUG INTERACTIONS )
  • Angle-closure glaucoma
  • Stenosing peptic ulcer. …
Warnings

Children - Overdosage of antihistamines, particularly in infants and children, may produce hallucinations, central nervous system depression, convulsions, and death. Antihistamines may diminish mental alertness conversely particularly in the young child they may occasionally produce excitation. CNS Depressants - Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents. Activities Requiring Mental Alertness - Patients should be warned about engaging in activities requiring mental alertness and motor coordination, such as driving a car or operating machinery. …

Possible side effects

Adverse reactions which have been reported with the use of antihistamines are as follows: Central Nervous System: Sedation and sleepiness (often transient), dizziness, disturbed coordination, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, paresthesias, neuritis, convulsions, euphoria, hallucinations, hysteria, faintness. Integumentary: Allergic manifestation of rash and edema, excessive perspiration, urticaria, photosensitivity. Special Senses: Acute labyrinthitis, blurred vision, diplopia, vertigo, tinnitus. Cardiovascular: Hypotension, palpitation, tachycardia, extrasystoles, anaphylactic shock. …

Pregnancy and breastfeeding

PREGNANCY Pregnancy Category B: Reproduction studies have been performed in rabbits, mice, and rats at oral or subcutaneous doses up to 32 times the maximum recommended human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to cyproheptadine. Cyproheptadine has been shown to be fetotoxic in rats when given by intraperitoneal injection in doses four times the maximum recommended human oral dose. …

If you take too much

Antihistamine overdosage reactions may vary from central nervous system depression to stimulation, especially in children. Also, atropine-like signs and symptoms (dry mouth; fixed, dilated pupils; flushing, etc.) as well as gastrointestinal symptoms may occur. If vomiting has not occurred spontaneously, the patient should be induced to vomit with syrup of ipecac. If patient is unable to vomit, perform gastric lavage followed by activated charcoal. Isotonic or 1/2 isotonic saline is the lavage of choice. Precautions against aspiration must be taken, especially in infants and children. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-01-27.

Label for cyproheptadine and vitamins, the active ingredient registered with NAFDAC.

Check your pack of Apetafast Syrup

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Apetafast Syrup

What is in Apetafast Syrup?

Apetafast Syrup contains Cyproheptadine; Vitamins (see Composition), as syrup, according to its NAFDAC registration record.

Is Apetafast Syrup registered with NAFDAC?

Yes. Apetafast Syrup is listed on the NAFDAC register under registration number C4-1198, and its registration is active as of 31 October 2026.

Has Apetafast Syrup been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Apetafast Syrup in our automatically synced alert list.

How can I check that my pack of Apetafast Syrup is genuine?

Run a free authenticity scan with the NAFDAC number C4-1198, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Apetafast Syrup?

Follow your prescription or the leaflet in your pack. The official label says: DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT. Children: The total daily dosage for children may be calculated on the basis of body weight or body area using approximately 0.25 mg/kg/day (0.11 mg/lb/day) or 8 mg per square meter of body surface (8 mg/m 2 ). In small children for whom the calculation of the dosage based upon body size is …

What is Apetafast Syrup used for?

Perennial and seasonal allergic rhinitis, Vasomotor rhinitis, Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Cold urticaria. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute man (Summarised from the official U.S. FDA label for cyproheptadine and vitamins. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Apetafast Syrup? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.